EAH - Ticker AI Digest

Eco Animal Health Group Plc 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (EAH) 1
EAH 06:01
Eco Animal Health Group Plc
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Share <mark style="background-coloryellow">Purchase</mark> by Executive Director
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 1
EAH 06:01
Eco Animal Health Group Plc
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Share <mark style="background-coloryellow">Purchase</mark> by Executive Director
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 1
EAH 06:01
Eco Animal Health Group Plc
Trading Update
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Here is a summary of the key points from the trading update provided by ECO Animal Health Group plc
ECO Animal Health Group plc expects to report adjusted EBITDA marginally ahead of market expectations for the year ended March 31, 2025, despite challenging market conditions.
The improved profitability is attributed to strong gross margins of over 45% and effective overhead cost control.
Total cash on hand as of March 31, 2025, was approximately £25 million, higher than the consensus estimate of £19 million.
The company faced currency headwindsgeopolitical uncertaintyand persistent market challengesparticularly in South-East Asiawhich impacted revenue.
Revenue for the year is expected to be approximately 7% below market expectations (5% on a constant currency basis).
ECO Animal Health Group has implemented strategies to mitigate the impact of tariffs arising from US trade policies and remains vigilant about the macroeconomic outlook.
The company continues to invest in new product innovation and believes its R&D pipeline will drive future growth, with a focus on vaccines for pigs and poultry.
ECO Animal Health Groups lead product, Aivlosin®, is a proprietary medication effective against respiratory and intestinal diseases in pigs and poultry.
The company remains optimistic about its ability to drive value in the coming months and years, particularly through its R&D pipeline.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 2
EAH 06:01
Eco Animal Health Group Plc
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Share <mark style="background-coloryellow">Purchase</mark> by Executive Director
EAH 06:01
Eco Animal Health Group Plc
Trading Update
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Here is a summary of the key points from the trading update provided by ECO Animal Health Group plc
ECO Animal Health Group plc expects to report adjusted EBITDA marginally ahead of market expectations for the year ended March 31, 2025, despite challenging market conditions.
The improved profitability is attributed to strong gross margins of over 45% and effective overhead cost control.
Total cash on hand as of March 31, 2025, was approximately £25 million, higher than the consensus estimate of £19 million.
The company faced currency headwindsgeopolitical uncertaintyand persistent market challengesparticularly in South-East Asiawhich impacted revenue.
Revenue for the year is expected to be approximately 7% below market expectations (5% on a constant currency basis).
ECO Animal Health Group has implemented strategies to mitigate the impact of tariffs arising from US trade policies and remains vigilant about the macroeconomic outlook.
The company continues to invest in new product innovation and believes its R&D pipeline will drive future growth, with a focus on vaccines for pigs and poultry.
ECO Animal Health Groups lead product, Aivlosin®, is a proprietary medication effective against respiratory and intestinal diseases in pigs and poultry.
The company remains optimistic about its ability to drive value in the coming months and years, particularly through its R&D pipeline.

AI Crunch

Single-Ticker AI Crunch
EAH signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Eco Animal Health Group Plc. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full EAH AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for EAH on 2025-04-28.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
66477328
Enterprise Value
52609039
Public Float
88.89
Broker Target
179.167
Shares Out
67084671
Long Interest
100
Short Interest
-
Exchange
LSE
Currency Code
GBX
ISIN
GB0032036807
Market
LSE - AIM
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2021-09-23
Earnings Date
2025-11-26
Net Debt
-21221000.0
Cash
25006000.0
EPS
0.04
Net Income
1686000.0
Revenue
79596000.0
Enterprise Value
52609039
Trailing PE
24.625
Forward PE
24.4499
Price Sales TTM
0.7747
Price Book MRQ
0.7401
EV Revenue
0.5728
EV EBITDA
5.0918

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
26.9466
Institutions As Of
2026-01-19
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
3
Sale Director Dealing
0
Purchase TR1
3
Sale TR1
2
Broker Coverage Rows
0
Institution Holders Tracked
3
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit EAH.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2025-04-28 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
Eco Animal Health Group Plc has fresh news flow feeding the chart narrative.
AI Charts Studio
EAH Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-04-28 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast 43.29%
RSI Gauge
Price Change
AI Forecast